Home/Filings/4/0001062993-22-016324
4//SEC Filing

Beck Martin S A 4

Accession 0001062993-22-016324

CIK 0001770141other

Filed

Jul 12, 8:00 PM ET

Accepted

Jul 13, 8:13 PM ET

Size

11.9 KB

Accession

0001062993-22-016324

Insider Transaction Report

Form 4
Period: 2022-07-11
Beck Martin S A
Chief Financial Officer
Transactions
  • Award

    Performance-Based Restricted Stock Unit

    2022-07-11+125,000125,000 total
    Exercise: $0.00Common Stock (125,000 underlying)
  • Award

    Common Stock

    2022-07-11+125,000345,208 total
  • Award

    Common Stock

    2022-07-11+90,000435,208 total
Holdings
  • Common Stock

    220,208
  • Common Stock

    (indirect: By LLC)
    1,222,082
  • Common Stock

    (indirect: By LLC)
    1,861,645
Footnotes (5)
  • [F1]Subject to the Reporting Person's continued service to UpHealth, Inc. (the "Company"), 1/3 of the Restricted Stock Unit ("RSUs") shall vest on May 1, 2023 (the "Initial Vesting Date"), and the remaining 2/3 of the RSUs shall vest quarterly on each of three month anniversary following the Initial Vesting Date until fully vested.
  • [F2]Subject to the Reporting Person's continued service to the Company, 50% of the RSU shall vest on August 22, 2022 and the remaining 50% will shall vest on June 1, 2023.
  • [F3]Mr. Beck has been an indirect equity owner and is the chairman of the board of directors of TTC Healthcare Partners, LLC ("TTC"), and as such, Mr. Beck may be deemed the beneficial owner of shares owned by TTC. Mr. Beck disclaims beneficial ownership of the shares held by TTC, except to the extent of his pecuniary interest therein, and the reporting herein of the shares held by TTC shall not be construed as an admission that Mr. Beck is the beneficial owner of those shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.
  • [F4]Rewi Enterprises, LLC, which is a direct member of TTC and of which Mr. Beck is the sole owner.
  • [F5]Each performance-based RSU represents the right to receive, following vesting, one share of the Company's common stock ("Common Stock"). The number of shares of Common Stock acquired upon vesting of the performance-based RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Board of Directors on an annual basis over three one-year performance periods beginning on the first day of the fiscal year of 2022 and ending on the last day of the fiscal year of 2024.

Issuer

UpHealth, Inc.

CIK 0001770141

Entity typeother

Related Parties

1
  • filerCIK 0001866167

Filing Metadata

Form type
4
Filed
Jul 12, 8:00 PM ET
Accepted
Jul 13, 8:13 PM ET
Size
11.9 KB